Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 9Wilms Tumor 2Pancreatic Neoplasms 2Kidney Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hepatic Veno-Occlusive Disease 1Genetic Predisposition to Disease 1Colorectal Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

spartalizumab 1pembrolizumab 1guadecitabine 1gallium Ga 68 dotatate 1belzutifan 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Genetic Testing 1Fluorodeoxyglucose F18 1Everolimus 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraganglioma × Genetic Testing × Genitourinary × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡